Nifty

:

25175.40

Sensex

:

81857.48

126.75 (0.51%)
319.78 (0.39%)

Login

Nifty
Sensex

:
:

25175.40
81857.48

126.75 (0.51%)
319.78 (0.39%)

Supriya Lifescience Ltd.

Pharmaceuticals & Drugs

Rating :

77/99

BSE: 543434 | NSE: SUPRIYA

Watchlist

NSE BSE

684.00

27-Jan-2026

Open
High
Low
Previous Close

721
723.8
671.35
716.05

Volume
Traded Value (lacs)
52 Week High
52 Week Low

261118
180765856.65
842
556.15

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

5,500.60
30.16
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

5,397.38
0.15%
5.08

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

15.10
12.23
14.75

EBITDA CAGR (%)

10 Years
5 Years
3 Years

29.51
8.55
15.23

PAT CAGR (%)

10 Years
5 Years
3 Years

41.87
8.75
27.89

P:E (Median)

8 Years
5 Years
3 Years

-
25.58
27.70

P:BV (Average)

8 Years
5 Years
3 Years

-
4.25
4.41

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
16.45
17.28

Earnings Forecasts:

(Updated: 24-01-2026)

Description 2024 2025 2026 2027
Adj EPS 23.35 24.9 30.5 39.8
P/E Ratio 29.29 27.47 22.43 17.19
Revenue 696.49 835.8 1002.9 1253.7
EBITDA 260.8 280 341 438.8
Net Income 187.96 200.1 245.3 320.2
ROA 18.49
P/B Ratio 5.52 4.63 3.86 3.17
ROE 20.74 16.8 17.2 18.4
FCFF 10.19 110 150 90
FCFF Yield 0.17 1.86 2.54 1.52
Net Debt -73.77
BVPS 123.85 147.7 177.2 216

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var%
Net Sales 199.83 166.10 20.31% 145.07 160.63 -9.69% 184.11 158.18 16.39% 185.65 140.07 32.54%
Expenses 127.19 101.39 25.45% 93.37 98.08 -4.80% 116.52 102.68 13.48% 119.70 98.59 21.41%
EBITDA 72.65 64.72 12.25% 51.70 62.54 -17.33% 67.58 55.50 21.77% 65.95 41.49 58.95%
EBIDTM 36.35% 38.96% 35.64% 38.94% 36.71% 35.09% 35.53% 29.62%
Other Income 2.73 2.52 8.33% 2.67 2.22 20.27% 2.98 2.19 36.07% 2.10 3.06 -31.37%
Interest 0.42 0.43 -2.33% 0.51 0.34 50.00% 0.42 0.60 -30.00% 0.51 0.49 4.08%
Depreciation 6.64 4.74 40.08% 6.45 4.66 38.41% 6.08 3.91 55.50% 4.96 3.96 25.25%
PBT 68.32 62.06 10.09% 47.41 59.77 -20.68% 64.06 53.17 20.48% 62.58 40.10 56.06%
Tax 17.89 15.92 12.37% 12.62 15.13 -16.59% 13.68 16.24 -15.76% 15.80 10.31 53.25%
PAT 50.43 46.15 9.27% 34.79 44.64 -22.07% 50.38 36.93 36.42% 46.78 29.79 57.03%
PATM 25.23% 27.78% 23.98% 27.79% 27.37% 23.35% 25.20% 21.27%
EPS 6.26 5.73 9.25% 4.32 5.55 -22.16% 6.26 4.59 36.38% 5.81 3.70 57.03%

Description Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 714.66 696.49 570.34 460.94 530.05 391.22 311.64 277.84 212.91 183.50 170.66 Net Sales Growth 14.35% 22.12% 23.73% -13.04% 35.49% 25.54% 12.17% 30.50% 16.03% 7.52% Cost Of Goods Sold 204.10 211.18 221.74 180.81 195.80 128.13 138.48 146.87 135.50 122.98 107.43 Gross Profit 510.56 485.31 348.60 280.13 334.24 263.09 173.16 130.96 77.41 60.52 63.22 GP Margin 71.44% 69.68% 61.12% 60.77% 63.06% 67.25% 55.56% 47.14% 36.36% 32.98% 37.04% Total Expenditure 456.78 435.56 394.65 332.50 316.06 218.07 213.26 213.41 190.96 166.38 151.00 Power & Fuel Cost - 24.80 21.37 20.95 14.07 9.24 8.97 8.06 7.03 6.93 6.64 % Of Sales - 3.56% 3.75% 4.55% 2.65% 2.36% 2.88% 2.90% 3.30% 3.78% 3.89% Employee Cost - 80.52 67.64 55.58 49.08 32.76 25.59 18.97 16.30 12.61 10.48 % Of Sales - 11.56% 11.86% 12.06% 9.26% 8.37% 8.21% 6.83% 7.66% 6.87% 6.14% Manufacturing Exp. - 50.18 35.34 28.71 20.01 14.05 15.29 18.59 14.36 9.35 5.82 % Of Sales - 7.20% 6.20% 6.23% 3.78% 3.59% 4.91% 6.69% 6.74% 5.10% 3.41% General & Admin Exp. - 27.54 21.66 16.73 11.05 8.76 9.08 6.92 8.02 8.17 10.14 % Of Sales - 3.95% 3.80% 3.63% 2.08% 2.24% 2.91% 2.49% 3.77% 4.45% 5.94% Selling & Distn. Exp. - 34.74 22.17 24.16 22.56 23.12 13.72 11.54 9.18 2.84 3.55 % Of Sales - 4.99% 3.89% 5.24% 4.26% 5.91% 4.40% 4.15% 4.31% 1.55% 2.08% Miscellaneous Exp. - 6.60 4.73 5.56 3.49 2.02 2.12 2.45 0.57 3.50 3.55 % Of Sales - 0.95% 0.83% 1.21% 0.66% 0.52% 0.68% 0.88% 0.27% 1.91% 4.06% EBITDA 257.88 260.93 175.69 128.44 213.99 173.15 98.38 64.43 21.95 17.12 19.66 EBITDA Margin 36.08% 37.46% 30.80% 27.86% 40.37% 44.26% 31.57% 23.19% 10.31% 9.33% 11.52% Other Income 10.48 9.82 10.96 9.94 7.58 5.00 11.07 8.33 8.59 7.45 2.39 Interest 1.86 1.83 5.15 3.08 4.20 4.08 6.85 10.22 10.75 11.76 10.04 Depreciation 24.13 20.44 15.81 11.81 10.12 6.76 6.38 5.43 5.33 4.75 3.95 PBT 242.37 248.48 165.69 123.49 207.24 167.31 96.23 57.10 14.46 8.06 8.06 Tax 59.99 60.52 46.58 33.63 55.44 43.72 22.82 17.68 5.74 2.40 2.37 Tax Rate 24.75% 24.36% 28.11% 27.23% 26.75% 26.13% 23.71% 30.96% 39.70% 29.78% 29.40% PAT 182.38 187.96 119.11 89.86 151.81 123.59 73.40 39.42 8.73 5.66 5.69 PAT before Minority Interest 182.38 187.96 119.11 89.86 151.81 123.59 73.40 39.42 8.73 5.66 5.69 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 25.52% 26.99% 20.88% 19.49% 28.64% 31.59% 23.55% 14.19% 4.10% 3.08% 3.33% PAT Growth 15.79% 57.80% 32.55% -40.81% 22.83% 68.38% 86.20% 351.55% 54.24% -0.53% EPS 22.66 23.35 14.80 11.16 18.86 15.35 9.12 4.90 1.08 0.70 0.71

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 996.76 815.37 699.46 615.69 268.58 149.19 93.79 54.66 45.89 41.72 Share Capital 16.10 16.10 16.10 16.10 14.64 14.64 14.64 14.64 14.64 14.64 Total Reserves 980.66 799.27 683.36 599.59 253.95 134.56 79.15 40.02 31.25 26.04 Non-Current Liabilities 33.39 28.98 25.04 19.38 30.86 31.85 24.36 44.86 51.30 39.21 Secured Loans 0.00 0.00 0.00 0.00 0.00 2.39 8.14 35.33 43.78 30.57 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.62 3.84 Long Term Provisions 1.32 0.80 5.88 2.93 1.30 1.03 0.69 0.58 0.00 0.00 Current Liabilities 87.19 79.57 95.78 99.70 146.02 155.39 134.91 145.88 144.15 150.26 Trade Payables 74.55 59.57 64.23 48.97 51.02 49.39 44.13 41.75 40.69 49.79 Other Current Liabilities 11.46 19.64 9.50 22.61 11.48 25.67 8.24 14.82 5.94 4.21 Short Term Borrowings 0.00 0.00 16.63 21.30 67.41 76.68 77.21 85.74 94.67 94.69 Short Term Provisions 1.19 0.37 5.42 6.82 16.11 3.64 5.33 3.56 2.84 1.57 Total Liabilities 1,117.34 923.92 820.28 734.77 445.46 336.43 253.06 245.40 241.34 231.19 Net Block 452.87 310.13 261.54 189.77 100.04 97.99 84.68 91.01 88.78 75.45 Gross Block 534.00 370.82 306.49 222.92 123.06 114.08 94.56 95.58 97.53 89.25 Accumulated Depreciation 81.13 60.69 44.95 33.14 23.03 16.08 9.88 4.57 8.75 13.80 Non Current Assets 675.28 523.43 355.39 237.22 180.00 138.44 120.39 125.82 126.31 102.29 Capital Work in Progress 148.01 148.82 67.63 43.41 78.79 40.21 35.35 34.38 35.58 25.18 Non Current Investment 63.24 63.80 25.30 0.05 0.05 0.05 0.05 0.12 0.10 0.10 Long Term Loans & Adv. 11.15 0.68 0.93 3.98 1.13 0.18 0.30 0.32 1.84 1.55 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 442.07 400.48 464.89 497.54 265.46 197.99 132.66 119.57 115.04 128.91 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 118.35 85.25 115.77 92.31 72.48 49.46 30.73 31.70 38.22 53.04 Sundry Debtors 134.36 111.68 84.66 115.18 73.50 52.49 59.95 53.40 49.61 42.34 Cash & Bank 79.15 74.96 157.58 227.91 89.28 1.54 1.73 2.73 5.58 7.09 Other Current Assets 110.21 15.95 17.25 13.28 30.20 94.51 40.25 31.74 21.63 26.44 Short Term Loans & Adv. 99.04 112.65 89.62 48.86 26.19 93.40 39.93 31.11 20.34 25.80 Net Current Assets 354.88 320.91 369.11 397.84 119.44 42.60 -2.25 -26.30 -29.11 -21.35 Total Assets 1,117.35 923.91 820.28 734.76 445.46 336.43 253.05 245.39 241.35 231.20

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 164.68 113.31 63.61 48.80 75.89 116.06 48.88 27.75 27.30 13.50 PBT 248.48 165.69 123.49 207.24 167.31 96.23 57.10 14.46 8.06 8.06 Adjustment 13.73 2.40 4.61 6.87 5.39 10.24 12.67 15.78 16.47 13.30 Changes in Working Capital -38.36 -17.14 -33.81 -104.35 -66.82 36.60 -6.80 0.80 2.87 -6.74 Cash after chg. in Working capital 223.85 150.95 94.29 109.76 105.88 143.07 62.98 31.04 27.40 14.62 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -59.18 -37.65 -30.68 -60.96 -29.99 -27.00 -14.09 -3.29 -0.10 -0.46 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.66 Cash From Investing Activity -152.24 -173.57 -123.65 -59.82 -46.80 -24.52 4.83 -4.71 -26.61 -32.83 Net Fixed Assets -162.37 -145.52 -107.79 -64.48 -47.56 -24.38 0.05 3.15 -18.68 -32.46 Net Investments 0.56 -38.50 -25.25 0.00 0.00 0.00 0.07 -0.02 0.00 0.00 Others 9.57 10.45 9.39 4.66 0.76 -0.14 4.71 -7.84 -7.93 -0.37 Cash from Financing Activity -8.23 -22.36 -10.28 149.65 -14.52 -29.23 -49.92 -20.01 -2.21 21.36 Net Cash Inflow / Outflow 4.20 -82.63 -70.32 138.63 14.57 62.31 3.79 3.03 -1.51 2.03 Opening Cash & Equivalents 74.96 157.58 227.91 89.28 74.70 12.40 8.61 5.58 7.09 5.06 Closing Cash & Equivalent 79.15 74.96 157.58 227.91 89.28 74.70 12.40 8.61 5.58 7.09

Financial Ratios

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 123.84 101.31 86.91 76.50 36.70 101.93 64.08 37.34 27.56 23.82 ROA 18.42% 13.66% 11.56% 25.73% 31.61% 24.90% 15.82% 4.65% 2.40% 2.80% ROE 20.74% 15.73% 13.66% 34.34% 59.17% 60.42% 53.11% 22.16% 15.05% 17.20% ROCE 27.63% 22.31% 18.71% 43.34% 60.12% 49.67% 36.52% 18.63% 11.48% 12.27% Fixed Asset Turnover 1.73 1.91 1.95 3.40 3.63 3.45 3.38 3.23 2.09 2.32 Receivable days 57.43 55.39 70.62 58.51 53.35 57.07 64.39 61.89 86.01 76.12 Inventory Days 47.52 56.71 73.53 51.10 51.64 40.70 35.46 47.13 85.36 90.25 Payable days 115.90 101.89 114.26 93.20 143.03 123.24 74.29 68.83 106.73 95.88 Cash Conversion Cycle -10.96 10.21 29.89 16.41 -38.04 -25.47 25.56 40.19 64.64 70.49 Total Debt/Equity 0.00 0.00 0.02 0.03 0.26 0.55 0.96 2.39 3.47 3.70 Interest Cover 137.08 33.18 41.04 50.37 42.01 15.05 6.59 2.34 1.69 1.80

Top Investors:

aditya birla sun life insurance company limited

cohesion mk best ideas sub-trust

Annual Reports:

News Update:

Supriya Lifescience aims up to Rs 1,600 crore revenue in next three years
17th Dec 2025, 11:39 AM

The company had a capex of Rs 160 crore for setting up its Ambernath facility
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback